- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00984698
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
February 14, 2014 updated by: Tricia Haynes, University of Arizona
The purpose of this study is to test the effectiveness of group psychotherapy designed specifically for male veterans and active-duty personnel with Post-traumatic Stress Disorder (PTSD), Major Depressive Disorder (MDD) and with disturbances in their sleep or daily routine.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The purpose of this study is to test the effectiveness of a group psychotherapy designed specifically for male veterans and active-duty personnel with Post-traumatic Stress Disorder (PTSD), Major Depressive Disorder (MDD) and with disturbances in their sleep or daily routine.
We will compare two group therapies, one of which has been examined in previous studies for veterans with PTSD.
Both group therapies have been shown to reduce symptoms of anxiety and depression in some veterans.
However, neither group therapy has been proven to be more effective than treatment as usual for PTSD.
Study Type
Interventional
Enrollment (Actual)
115
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85724
- University of Arizona
-
Tucson, Arizona, United States, 85723
- Southern Arizona VA Healthcare System (SAVAHCS)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Veteran or active duty military personnel
- Current posttraumatic stress disorder (PTSD), at least moderate severity
- Criterion A exposure to trauma occurring after the age of 18
- Major depressive disorder (MDD), at least moderate severity
- Disturbances in sleep (primary insomnia, insomnia related to PTSD, or nightmare disorder) or daily routine
Exclusion Criteria:
- Current or past bipolar disorder
- Current psychotic disorder
- Substance abuse/dependence in last 30 days
- Uncontrolled serious medical condition or neurological disorder
- Currently working an overnight shift
- Primary untreated sleep apnea, restless legs syndrome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Structured Therapy
Cognitive Behavioral Social Rhythm Group Therapy is designed to improve mood and sleep by stabilizing social rhythms, increasing exposure to ambient light, changing dysfunctional bed/bedtime associations, activating the imagery system by changing nightmare content, and challenging dysfunctional automatic thoughts that might contribute to behavioral inactivation and nonadherence to the therapy protocol.
There is no discussion of past traumatic events.
|
12 weeks, 2h structured group therapy
|
ACTIVE_COMPARATOR: Unstructured Therapy
Present Centered Group Therapy includes education about the typical symptoms and features associated with PTSD and MDD, with a focus on how these symptoms affect interpersonal relationships.
It uses the group format to decrease isolation, normalize symptoms, and provide the experience of giving and receiving support.
Some relaxation training is provided early in therapy.
There is no discussion of past traumatic events.
|
12 weeks, 2h relatively unstructured group therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression
Time Frame: post-treatment, at 12 weeks
|
Hamilton Rating Scale for Depression, 17 item The Hamilton Rating Scale for Depression is an interview assessment of depression symptom severity.
Total score range is from 0 (no symptoms of depression) to 52 (maximum symptoms of depression).
|
post-treatment, at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PTSD
Time Frame: post-treatment, at 12 weeks
|
Clinician-Administered PTSD Scale (CAPS), DSM-IV The CAPS is a 17-item interview assessment post-traumatic stress disorder (PTSD) symptom severity.
Total score ranges from 0 (no PTSD symptoms) to 136 (maximum PTSD symptoms).
|
post-treatment, at 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Patricia Haynes, PhD, University of Arizona
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (ACTUAL)
May 1, 2012
Study Completion (ACTUAL)
August 1, 2012
Study Registration Dates
First Submitted
September 24, 2009
First Submitted That Met QC Criteria
September 24, 2009
First Posted (ESTIMATE)
September 25, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
March 31, 2014
Last Update Submitted That Met QC Criteria
February 14, 2014
Last Verified
February 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Mental Disorders
- Pathologic Processes
- Nervous System Diseases
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Trauma and Stressor Related Disorders
- Depression
- Disease
- Sleep Initiation and Maintenance Disorders
- Stress Disorders, Traumatic
- Stress Disorders, Post-Traumatic
Other Study ID Numbers
- W81XWH-08-2-0121
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Cognitive Behavioral Social Rhythm Group Therapy
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)CompletedAttention Deficit Disorder With HyperactivityUnited States
-
University of PittsburghWithdrawnPsychosis | Prodromal Symptoms | Prodromal Stage | Prodromal StatesUnited States
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)RecruitingDepressionUnited States
-
Douglas Mental Health University InstituteCanadian Institutes of Health Research (CIHR)CompletedPsychosis | Social PhobiaCanada
-
Emory UniversityRecruitingDepression | Alcoholism | Drug AbuseUnited States
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderNorway
-
The Royal Ottawa Mental Health CentreEnrolling by invitationParaphilias and Paraphilic DisordersCanada
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
University of PittsburghCompletedBorderline Personality Disorder | Bipolar I DisorderUnited States
-
Heidelberg UniversityGerman Association for Systemic Therapy, Counseling and Family Therapy (DGSF) and other collaboratorsCompletedSocial Anxiety DisorderGermany